Nathan C. Skorodin

Statistics

Publications

Citations

136

H-Index

Active since

2016

Affiliations

Infectious Disease Consultants(Current)

Nathan C. Skorodin is an author at Infectious Disease Consultants specializing in pharmacotherapy, pharmacodynamics in critical illness, and pharmacy.

ORCID

Publications per year

2016–2021

Publications

A Real-World Assessment of Clinical Outcomes and Safety of Eravacycline: A Novel Fluorocycline

Nicholas Van Hise, Russell M. Petrak, Nathan C. Skorodin et al. · Infectious Diseases and Therapy · 2020 · 40 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Value and Clinical Impact of an Infectious Disease-Supervised Outpatient Parenteral Antibiotic Therapy Program

Russell M. Petrak, Nathan C. Skorodin, Robert Fliegelman et al. · Open Forum Infectious Diseases · 2016 · 39 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +13

Tocilizumab as a Therapeutic Agent for Critically Ill Patients Infected with SARS‐CoV‐2

Russell M. Petrak, Nathan C. Skorodin, Nicholas W. Van Hise et al. · Clinical and Translational Science · 2020 · 22 citations · Full text

Medicine, Immunology, Pharmacotherapy +17

Tocilizumab as a Therapeutic Agent for Critically Ill Patients Infected with SARS-CoV-2

Russell M. Petrak, Nathan C. Skorodin, Nicholas W. Van Hise et al. · medRxiv · 2020 · 20 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +15

Early Tocilizumab Dosing Is Associated With Improved Survival in Critically Ill Patients Infected With Severe Acute Respiratory Syndrome Coronavirus-2

Russell M. Petrak, Nicholas W. Van Hise, Nathan C. Skorodin et al. · Critical Care Explorations · 2021 · 15 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +16

1–5 of 5